News and Trends 26 May 2023Novartis buys AVROBIO cystinosis gene therapy program for $87.5M AVROBIO, Inc., a clinical-stage gene therapy company working to free people from a lifetime of genetic disease, has agreed to… May 26, 2023 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email